iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) Short Interest Update

iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) was the recipient of a large increase in short interest in June. As of June 15th, there was short interest totaling 12,988 shares, an increase of 134.2% from the May 31st total of 5,546 shares. Approximately 8.7% of the company’s stock are short sold. Based on an average trading volume of 2,385 shares, the days-to-cover ratio is currently 5.4 days.

iShares Neuroscience and Healthcare ETF Stock Performance

IBRN traded up $0.11 during trading on Tuesday, hitting $38.83. The stock had a trading volume of 5,740 shares, compared to its average volume of 2,021. The stock has a 50 day simple moving average of $35.33 and a two-hundred day simple moving average of $33.39. iShares Neuroscience and Healthcare ETF has a twelve month low of $21.89 and a twelve month high of $39.24. The company has a market capitalization of $5.82 million, a PE ratio of 15.61 and a beta of 0.77.

About iShares Neuroscience and Healthcare ETF

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is managed by BlackRock.